SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-180184
Filing Date
2022-06-23
Accepted
2022-06-23 16:26:03
Documents
12
Period of Report
2022-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d350734d8k.htm   iXBRL 8-K 29547
  Complete submission text file 0001193125-22-180184.txt   158480

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grph-20220621.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20220621_lab.xml EX-101.LAB 19502
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20220621_pre.xml EX-101.PRE 12158
6 EXTRACTED XBRL INSTANCE DOCUMENT d350734d8k_htm.xml XML 3565
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 221035816
SIC: 2836 Biological Products, (No Diagnostic Substances)